|
Diabetes, Vol 36, Issue 4 459-464, Copyright © 1987 by American Diabetes Association
Impaired insulin secretion associated with near normoglycemia. Study in normal rats with 96-h in vivo glucose infusions
JL Leahy, HE Cooper and GC Weir
We have previously demonstrated impaired glucose influence on insulin
secretion in normal rats made overtly hyperglycemic with glucose infusions
for 48 h. We examined the effects of a 96-h infusion period. Rats received
30, 35, or 50% glucose or 0.45% NaCl at 2 ml/h. The plasma glucose in the
30 and 35% rats peaked at 24 h but then returned to normal by 72 h. A peak
followed by a gradual fall also occurred in the 50% rats, but significant
hyperglycemia was maintained throughout. beta-Cell responsiveness to
glucose was assessed with the perfused pancreas by examining the effect of
altering the perfusate glucose concentration on insulin release. Insulin
secretion remained intact in the 30% rats, but the response to a glucose
increase was blunted in the 35% group and totally absent in the 50% rats.
In a second protocol, glucose influence on arginine-stimulated insulin
release was tested by adding 10 mM arginine to the perfusate and
administering it with 2.8 and 16.7 mM glucose. The ability of the different
glucose backgrounds to influence the insulin response decreased as the
level of infused glucose rose. On the other hand, when phloridzin was added
to 50% glucose during the second 48 h of infusion, glucose modulation of
insulin release was completely restored. These data indicate that during a
period of overt hyperglycemia, beta-cell defects can fully evolve within 48
h in the rat. Thereafter, they are maintained by the glucose infusion even
though the plasma glucose level returns to near normal. Continued minor
stimulation of the beta-cell may be the responsible factor.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Kooptiwut, M. Kebede, S. Zraika, S. Visinoni, K. Aston-Mourney, J. Favaloro, C. Tikellis, M. C Thomas, J. M Forbes, M. E Cooper, et al.
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction
J. Mol. Endocrinol.,
August 1, 2005;
35(1):
39 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. DeFronzo, R. M. Bergenstal, W. T. Cefalu, J. Pullman, S. Lerman, B. W. Bode, L. S. Phillips, and for the Exubera Phase III Study Group
Efficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise: A 12-week, randomized, comparative trial
Diabetes Care,
August 1, 2005;
28(8):
1922 - 1928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Teff and R. R. Townsend
Prolonged Mild Hyperglycemia Induces Vagally Mediated Compensatory Increase in C-Peptide Secretion in Humans
J. Clin. Endocrinol. Metab.,
November 1, 2004;
89(11):
5606 - 5613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Otani, R. N. Kulkarni, A. C. Baldwin, J. Krutzfeldt, K. Ueki, M. Stoffel, C. R. Kahn, and K. S. Polonsky
Reduced {beta}-cell mass and altered glucose sensing impair insulin-secretory function in {beta}IRKO mice
Am J Physiol Endocrinol Metab,
January 1, 2004;
286(1):
E41 - E49.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. M. Wolever and C. Mehling
Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance
Am. J. Clinical Nutrition,
March 1, 2003;
77(3):
612 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Steil, N. Trivedi, J.-C. Jonas, W. M. Hasenkamp, A. Sharma, S. Bonner-Weir, and G. C. Weir
Adaptation of {beta}-cell mass to substrate oversupply: enhanced function with normal gene expression
Am J Physiol Endocrinol Metab,
May 1, 2001;
280(5):
E788 - E796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Laybutt, C. Schmitz-Peiffer, A. K. Saha, N. B. Ruderman, T. J. Biden, and E. W. Kraegen
Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
Am J Physiol Endocrinol Metab,
December 1, 1999;
277(6):
E1070 - E1076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Saha, D. R. Laybutt, D. Dean, D. Vavvas, E. Sebokova, B. Ellis, I. Klimes, E. W. Kraegen, E. Shafrir, and N. B. Ruderman
Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo
Am J Physiol Endocrinol Metab,
June 1, 1999;
276(6):
E1030 - E1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Postic, M. Shiota, K. D. Niswender, T. L. Jetton, Y. Chen, J. M. Moates, K. D. Shelton, J. Lindner, A. D. Cherrington, and M. A. Magnuson
Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic beta Cell-specific Gene Knock-outs Using Cre Recombinase
J. Biol. Chem.,
January 1, 1999;
274(1):
305 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1987 by the American Diabetes Association.
|
|
| |
|